Prosecution Insights
Last updated: October 04, 2026

Prellis Biologics Inc.

Technology area: Chemistry & Materials

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Prellis Biologics Inc. has 1 pending office action in the Chemistry & Materials technology area. The portfolio involves 1 distinct examiner, Jeffrey Michael Wollschlager, and 1 distinct art unit. Jeffrey Michael Wollschlager is the busiest examiner, holding 1 pending office action. With only 1 pending action, the company's current prosecution is entirely focused under this single examiner. This suggests a very specific area of technological interest for the company's current filings.

The involvement of 1 distinct examiner and 1 distinct art unit means that the 1 pending office action will be reviewed according to a consistent set of standards. Because Jeffrey Michael Wollschlager is the only examiner involved, his specific history and the practices of the 1 distinct art unit are critical for the company's strategy. This centralized structure in the Chemistry & Materials sector allows for a streamlined management process. Practitioners can focus their efforts on a single point of contact at the patent office to resolve the company's active matters.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
2
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
2
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
AHMED ALI, MOHAMED K 1 71.0% +26.9%
WOLLSCHLAGER, JEFFREY MICHAEL 1 62.1% +29.6%

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18871132 METHODS AND SYSTEMS FOR THREE-DIMENSIONAL PRINTING AHMED ALI, MOHAMED K —
17703162 THREE-DIMENSIONAL PRINTED ORGANS, DEVICES, AND MATRICES WOLLSCHLAGER, JEFFREY MICHAEL —

Top Art Units

Art UnitApps
1743 1
1742 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18871132 METHODS AND SYSTEMS FOR THREE-DIMENSIONAL PRINTING AHMED ALI, MOHAMED K 1743 §103 Non-Final OA — Pending Dec 02, 2024
17703162 THREE-DIMENSIONAL PRINTED ORGANS, DEVICES, AND MATRICES WOLLSCHLAGER, JEFFREY MICHAEL 1742 §103 Non-Final OA — Pending Mar 24, 2022

Managing Prellis Biologics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month